Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

Free Abstracts

  Breast Cancer

  Free Subscription


12.02.2018

1 Am J Clin Oncol
1 Am J Surg
1 Anticancer Res
8 BMC Cancer
2 Breast Cancer
1 Breast Cancer (Dove Med Press)
2 Breast Cancer Res
8 Breast Cancer Res Treat
1 Breast J
1 Cancer
1 Cancer Chemother Pharmacol
3 Cancer Lett
3 Clin Breast Cancer
1 Clin Cancer Res
1 Eur J Cancer
2 Eur J Surg Oncol
3 Gene
1 Int J Cancer
2 Int J Oncol
2 J Surg Oncol
1 Lancet Oncol
1 Nat Rev Clin Oncol
2 Nature
1 Oncogene
1 Oncol Rep
1 Oncology
9 PLoS One
2 Radiother Oncol


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Clin Oncol

  1. CHOI SH, Chang JS, Koo JS, Park JW, et al
    Differential Prognostic Impact of Strong PD-L1 Expression and 18F-FDG Uptake in Triple-negative Breast Cancer.
    Am J Clin Oncol. 2018 Feb 6. doi: 10.1097/COC.0000000000000426.
    PubMed     Text format     Abstract available


    Am J Surg

  2. PAJAK C, Pao J, Ghuman A, McKevitt EC, et al
    Routine shave margins are not necessary in early stage breast cancer treated with Breast Conserving Surgery.
    Am J Surg. 2018 Jan 16. pii: S0002-9610(17)31640.
    PubMed     Text format     Abstract available


    Anticancer Res

  3. LUCZYNSKA E, Niemiec J, Heinze S, Adamczyk A, et al
    Intensity and Pattern of Enhancement on CESM: Prognostic Significance and its Relation to Expression of Podoplanin in Tumor Stroma - A Preliminary Report.
    Anticancer Res. 2018;38:1085-1095.
    PubMed     Text format     Abstract available


    BMC Cancer

  4. ALUNNI-FABBRONI M, Majunke L, Trapp EK, Tzschaschel M, et al
    Whole blood microRNAs as potential biomarkers in post-operative early breast cancer patients.
    BMC Cancer. 2018;18:141.
    PubMed     Text format     Abstract available

  5. CORTET M, Bertaut A, Molinie F, Bara S, et al
    Trends in molecular subtypes of breast cancer: description of incidence rates between 2007 and 2012 from three French registries.
    BMC Cancer. 2018;18:161.
    PubMed     Text format     Abstract available

  6. LAM WWT, Kwong A, Suen D, Tsang J, et al
    Factors predicting patient satisfaction in women with advanced breast cancer: a prospective study.
    BMC Cancer. 2018;18:162.
    PubMed     Text format     Abstract available

  7. LIM JA, Oh CS, Yoon TG, Lee JY, et al
    The effect of propofol and sevoflurane on cancer cell, natural killer cell, and cytotoxic T lymphocyte function in patients undergoing breast cancer surgery: an in vitro analysis.
    BMC Cancer. 2018;18:159.
    PubMed     Text format     Abstract available

  8. ABDEL-RAZEQ H, Al-Omari A, Zahran F, Arun B, et al
    Germline BRCA1/BRCA2 mutations among high risk breast cancer patients in Jordan.
    BMC Cancer. 2018;18:152.
    PubMed     Text format     Abstract available

  9. PENSABENE M, Stanzione B, Cerillo I, Ciancia G, et al
    It is no longer the time to disregard thyroid metastases from breast cancer: a case report and review of the literature.
    BMC Cancer. 2018;18:146.
    PubMed     Text format     Abstract available

  10. NOVAK J, Besic N, Dzodic R, Gazic B, et al
    Pre-operative and intra-operative detection of axillary lymph node metastases in 108 patients with invasive lobular breast cancer undergoing mastectomy.
    BMC Cancer. 2018;18:137.
    PubMed     Text format     Abstract available

  11. TRAORE BM, El Fakir S, Charaka H, Benaicha N, et al
    Evolution of quality of life in patients with breast cancer during the first year of follow-up in Morocco.
    BMC Cancer. 2018;18:109.
    PubMed     Text format     Abstract available


    Breast Cancer

  12. ZOU L, Liu FH, Shen PP, Hu Y, et al
    The incidence and risk factors of related lymphedema for breast cancer survivors post-operation: a 2-year follow-up prospective cohort study.
    Breast Cancer. 2018 Feb 3. pii: 10.1007/s12282-018-0830.
    PubMed     Text format     Abstract available

  13. IWATA H
    Clinical development of CDK4/6 inhibitor for breast cancer.
    Breast Cancer. 2018 Feb 1. pii: 10.1007/s12282-017-0827.
    PubMed     Text format     Abstract available


    Breast Cancer (Dove Med Press)

  14. SZMYD M, Lloyd V, Hallman K, Aleck K, et al
    The effects of black cohosh on the regulation of estrogen receptor (ERalpha) and progesterone receptor (PR) in breast cancer cells.
    Breast Cancer (Dove Med Press). 2018;10:1-11.
    PubMed     Text format     Abstract available


    Breast Cancer Res

  15. ALLOTT EH, Geradts J, Cohen SM, Khoury T, et al
    Frequency of breast cancer subtypes among African American women in the AMBER consortium.
    Breast Cancer Res. 2018;20:12.
    PubMed     Text format     Abstract available

  16. ROXANIS I, Colling R, Kartsonaki C, Green AR, et al
    The significance of tumour microarchitectural features in breast cancer prognosis: a digital image analysis.
    Breast Cancer Res. 2018;20:11.
    PubMed     Text format     Abstract available


    Breast Cancer Res Treat

  17. JANNI W, Alba E, Bachelot T, Diab S, et al
    First-line ribociclib plus letrozole in postmenopausal women with HR+ , HER2- advanced breast cancer: Tumor response and pain reduction in the phase 3 MONALEESA-2 trial.
    Breast Cancer Res Treat. 2018 Feb 5. pii: 10.1007/s10549-017-4658.
    PubMed     Text format     Abstract available

  18. FOLDI J, Mougalian S, Silber A, Lannin D, et al
    Single-arm, neoadjuvant, phase II trial of pertuzumab and trastuzumab administered concomitantly with weekly paclitaxel followed by 5-fluoruracil, epirubicin, and cyclophosphamide (FEC) for stage I-III HER2-positive breast cancer.
    Breast Cancer Res Treat. 2018 Feb 2. pii: 10.1007/s10549-017-4653.
    PubMed     Text format     Abstract available

  19. MATOSSIAN MD, Burks HE, Bowles AC, Elliott S, et al
    A novel patient-derived xenograft model for claudin-low triple-negative breast cancer.
    Breast Cancer Res Treat. 2018 Feb 1. pii: 10.1007/s10549-018-4685.
    PubMed     Text format     Abstract available

  20. WEBER WP, Soysal SD, El-Tamer M, Sacchini V, et al
    First international consensus conference on standardization of oncoplastic breast conserving surgery.
    Breast Cancer Res Treat. 2017;165:139-149.
    PubMed     Text format     Abstract available

  21. VALDORA F, Houssami N, Rossi F, Calabrese M, et al
    Rapid review: radiomics and breast cancer.
    Breast Cancer Res Treat. 2018 Feb 2. pii: 10.1007/s10549-018-4675.
    PubMed     Text format     Abstract available

  22. ZAREI N, Fazeli M, Mohammadi M, Nejatollahi F, et al
    Cell growth inhibition and apoptosis in breast cancer cells induced by anti-FZD7 scFvs: involvement of bioinformatics-based design of novel epitopes.
    Breast Cancer Res Treat. 2018 Feb 6. pii: 10.1007/s10549-017-4641.
    PubMed     Text format     Abstract available

  23. COSTA RLB, Han HS, Gradishar WJ
    Targeting the PI3K/AKT/mTOR pathway in triple-negative breast cancer: a review.
    Breast Cancer Res Treat. 2018 Feb 7. pii: 10.1007/s10549-018-4697.
    PubMed     Text format     Abstract available

  24. LAMMERT J, Lubinski J, Gronwald J, Huzarski T, et al
    Physical activity during adolescence and young adulthood and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers.
    Breast Cancer Res Treat. 2018 Feb 5. pii: 10.1007/s10549-018-4694.
    PubMed     Text format     Abstract available


    Breast J

  25. SWINTELSKI C, Plaza M
    Successful cryoablation of breast cancer.
    Breast J. 2018 Feb 7. doi: 10.1111/tbj.12996.
    PubMed     Text format     Abstract available


    Cancer

  26. PRINTZ C
    Patients with breast cancer who are treated with chemotherapy risk long-term nerve damage.
    Cancer. 2018;124:663.
    PubMed     Text format    


    Cancer Chemother Pharmacol

  27. LIU Z, Tao Z, Zhang Q, Wan S, et al
    YSA-conjugated mesoporous silica nanoparticles effectively target EphA2-overexpressing breast cancer cells.
    Cancer Chemother Pharmacol. 2018 Feb 1. pii: 10.1007/s00280-018-3535.
    PubMed     Text format     Abstract available


    Cancer Lett

  28. GANNON OM, Antonsson A, Bennett IC, Saunders NA, et al
    Viral infections and breast cancer - A current perspective.
    Cancer Lett. 2018 Feb 2. pii: S0304-3835(18)30117.
    PubMed     Text format     Abstract available

  29. WANG QS, He R, Yang F, Kang LJ, et al
    FOXF2 deficiency permits basal-like breast cancer cells to form lymphangiogenic mimicry by enhancing the response of VEGF-C/VEGFR3 signaling pathway.
    Cancer Lett. 2018 Jan 30. pii: S0304-3835(18)30102.
    PubMed     Text format     Abstract available

  30. LYU H, Wang S, Huang J, Wang B, et al
    Survivin-targeting miR-542-3p overcomes HER3 signaling-induced chemoresistance and enhances the antitumor activity of paclitaxel against HER2-overexpressing breast cancer.
    Cancer Lett. 2018 Jan 30. pii: S0304-3835(18)30098.
    PubMed     Text format     Abstract available


    Clin Breast Cancer

  31. GU J, Groot G, Boden C, Busch A, et al
    Review of Factors Influencing Women's Choice of Mastectomy Versus Breast Conserving Therapy in Early Stage Breast Cancer: A Systematic Review.
    Clin Breast Cancer. 2018 Jan 3. pii: S1526-8209(17)30691.
    PubMed     Text format     Abstract available

  32. YADAV S, Ladkany R, Yadav D, Alhalabi O, et al
    Impact of BRCA Mutation Status on Survival of Women With Triple-negative Breast Cancer.
    Clin Breast Cancer. 2017 Dec 30. pii: S1526-8209(17)30334.
    PubMed     Text format     Abstract available

  33. YERUVA SLH, Javadi MS, Stearns V
    Complete Response to Single-agent Palbociclib in Metastatic Breast Cancer: A Case Report.
    Clin Breast Cancer. 2017 Dec 21. pii: S1526-8209(17)30533.
    PubMed     Text format    


    Clin Cancer Res

  34. GONG C, Man EP, Tsoi H, Lee TK, et al
    BQ323636.1, a Novel Splice Variant to NCOR2, as a Predictor for Tamoxifen Resistant Breast Cancer.
    Clin Cancer Res. 2018 Feb 2. pii: 1078-0432.CCR-17-2259.
    PubMed     Text format     Abstract available


    Eur J Cancer

  35. LOKE SY, Lee ASG
    The future of blood-based biomarkers for the early detection of breast cancer.
    Eur J Cancer. 2018;92:54-68.
    PubMed     Text format     Abstract available


    Eur J Surg Oncol

  36. LIAO GS
    Reply letter to: Role of endocrine therapy in weak estrogen/progesterone receptor expression in HER2 negative breast cancer.
    Eur J Surg Oncol. 2018 Jan 27. pii: S0748-7983(18)30117.
    PubMed     Text format    

  37. SASADA S, Masumoto N, Goda N, Kajitani K, et al
    Dedicated breast PET for detecting residual disease after neoadjuvant chemotherapy in operable breast cancer: A prospective cohort study.
    Eur J Surg Oncol. 2018 Jan 17. pii: S0748-7983(18)30044.
    PubMed     Text format     Abstract available


    Gene

  38. RAGHAVAN S, Venkatraman G, Rayala SK
    Cloning and functional characterization of human Pak1 promoter by steroid hormones.
    Gene. 2018;646:120-128.
    PubMed     Text format     Abstract available

  39. GHALI R, Al-Mutawa MA, Al-Ansari AK, Zaied S, et al
    Differential association of ESR1 and ESR2 gene variants with the risk of breast cancer and associated features: A case-control study.
    Gene. 2018 Feb 4. pii: S0378-1119(18)30140-9. doi: 10.1016/j.gene.2018.
    PubMed     Text format     Abstract available

  40. LI XP, Lan JY, Liu DQ, Zhou H, et al
    OCA2 rs4778137 polymorphism predicts survival of breast cancer patients receiving neoadjuvant chemotherapy.
    Gene. 2018 Feb 1. pii: S0378-1119(18)30121-5. doi: 10.1016/j.gene.2018.
    PubMed     Text format     Abstract available


    Int J Cancer

  41. LAN B, Ma F, Zhai X, Li Q, et al
    The relationship between the CYP2D6 polymorphisms and tamoxifen efficacy in adjuvant endocrine therapy of breast cancer patients in Chinese Han population.
    Int J Cancer. 2018 Feb 3. doi: 10.1002/ijc.31291.
    PubMed     Text format     Abstract available


    Int J Oncol

  42. PENG F, Li Q, Sun JY, Luo Y, et al
    PFKFB3 is involved in breast cancer proliferation, migration, invasion and angiogenesis.
    Int J Oncol. 2018 Jan 30. doi: 10.3892/ijo.2018.4257.
    PubMed     Text format     Abstract available

  43. ZHONG R, Liang B, Xin R, Zhu X, et al
    Deoxycytidine kinase participates in the regulation of radiation-induced autophagy and apoptosis in breast cancer cells.
    Int J Oncol. 2018 Jan 22. doi: 10.3892/ijo.2018.4250.
    PubMed     Text format     Abstract available


    J Surg Oncol

  44. PATTEN CR, Walsh K, Sarantou T, Hadzikadic-Gusic L, et al
    Changes in margin re-excision rates: Experience incorporating the "no ink on tumor" guideline into practice.
    J Surg Oncol. 2017;116:1040-1045.
    PubMed     Text format     Abstract available

  45. HWANG H, Park S, Koo JS, Park HS, et al
    Factors predictive of occult nipple-areolar complex involvement in patients with carcinoma in situ of the breast.
    J Surg Oncol. 2017;116:1046-1055.
    PubMed     Text format     Abstract available


    Lancet Oncol

  46. BIANUCCI R, Perciaccante A, Charlier P, Appenzeller O, et al
    Earliest evidence of malignant breast cancer in Renaissance paintings.
    Lancet Oncol. 2018;19:166-167.
    PubMed     Text format    


    Nat Rev Clin Oncol

  47. ROMERO D
    Breast cancer: Recurrent fusions in endocrine-resistant disease.
    Nat Rev Clin Oncol. 2018 Feb 6. pii: nrclinonc.2018.
    PubMed     Text format    


    Nature

  48. KNOTT SRV, Wagenblast E, Khan S, Kim SY, et al
    Asparagine bioavailability governs metastasis in a model of breast cancer.
    Nature. 2018 Feb 7. pii: nature25465. doi: 10.1038/nature25465.
    PubMed     Text format     Abstract available

  49. GOEL S, DeCristo MJ, Watt AC, BrinJones H, et al
    CDK4/6 inhibition triggers anti-tumour immunity.
    Nature. 2017;548:471-475.
    PubMed     Text format     Abstract available


    Oncogene

  50. SAATCI O, Borgoni S, Akbulut O, Durmus S, et al
    Targeting PLK1 overcomes T-DM1 resistance via CDK1-dependent phosphorylation and inactivation of Bcl-2/xL in HER2-positive breast cancer.
    Oncogene. 2018 Feb 2. pii: 10.1038/s41388-017-0108.
    PubMed     Text format     Abstract available


    Oncol Rep

  51. HU B, Meng X, Zhang Y, Hossain MM, et al
    Short hairpin RNA-mediated gene silencing of ADAM17 inhibits the growth of breast cancer MCF7 cells in vitro and in vivo and its mechanism of action.
    Oncol Rep. 2018 Jan 26. doi: 10.3892/or.2018.6237.
    PubMed     Text format     Abstract available


    Oncology

  52. LEE SJ, Lee J, Kim WW, Jung JH, et al
    Del-1 Expression as a Potential Biomarker in Triple-Negative Early Breast Cancer.
    Oncology. 2018 Jan 31. pii: 000485658. doi: 10.1159/000485658.
    PubMed     Text format     Abstract available


    PLoS One

  53. THAKRAN S, Chatterjee S, Singhal M, Gupta RK, et al
    Automatic outer and inner breast tissue segmentation using multi-parametric MRI images of breast tumor patients.
    PLoS One. 2018;13:e0190348.
    PubMed     Text format     Abstract available

  54. VACHER S, Castagnet P, Chemlali W, Lallemand F, et al
    High AHR expression in breast tumors correlates with expression of genes from several signaling pathways namely inflammation and endogenous tryptophan metabolism.
    PLoS One. 2018;13:e0190619.
    PubMed     Text format     Abstract available

  55. PATEL N, Garikapati KR, Makani VKK, Nair AD, et al
    Regulating BMI1 expression via miRNAs promote Mesenchymal to Epithelial Transition (MET) and sensitizes breast cancer cell to chemotherapeutic drug.
    PLoS One. 2018;13:e0190245.
    PubMed     Text format     Abstract available

  56. JOFFE M, Ayeni O, Norris SA, McCormack VA, et al
    Barriers to early presentation of breast cancer among women in Soweto, South Africa.
    PLoS One. 2018;13:e0192071.
    PubMed     Text format     Abstract available

  57. BRADFORD JR, Cox A, Bernard P, Camp NJ, et al
    Correction: Consensus Analysis of Whole Transcriptome Profiles from Two Breast Cancer Patient Cohorts Reveals Long Non-Coding RNAs Associated with Intrinsic Subtype and the Tumour Microenvironment.
    PLoS One. 2018;13:e0192589.
    PubMed     Text format     Abstract available

  58. BELCHER DA, Ju JA, Baek JH, Yalamanoglu A, et al
    The quaternary state of polymerized human hemoglobin regulates oxygenation of breast cancer solid tumors: A theoretical and experimental study.
    PLoS One. 2018;13:e0191275.
    PubMed     Text format     Abstract available

  59. RUSSO-ABRAHAO T, Lacerda-Abreu MA, Gomes T, Cosentino-Gomes D, et al
    Characterization of inorganic phosphate transport in the triple-negative breast cancer cell line, MDA-MB-231.
    PLoS One. 2018;13:e0191270.
    PubMed     Text format     Abstract available

  60. KHAN MM, Mendes A, Chalup SK
    Evolutionary Wavelet Neural Network ensembles for breast cancer and Parkinson's disease prediction.
    PLoS One. 2018;13:e0192192.
    PubMed     Text format     Abstract available

  61. ZHANG J, Yang J, Zhang X, Xu J, et al
    MicroRNA-10b expression in breast cancer and its clinical association.
    PLoS One. 2018;13:e0192509.
    PubMed     Text format     Abstract available


    Radiother Oncol

  62. MIGUEZ C, Jimenez-Ortega E, Palma BA, Miras H, et al
    Clinical implementation of combined modulated electron and photon beams with conventional MLC for accelerated partial breast irradiation.
    Radiother Oncol. 2017;124:124-129.
    PubMed     Text format     Abstract available

  63. JANG BS, Kim IA
    A radiosensitivity gene signature and PD-L1 status predict clinical outcome of patients with invasive breast carcinoma in The Cancer Genome Atlas (TCGA) dataset.
    Radiother Oncol. 2017;124:403-410.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: